Julian Baker’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

Julian Baker’s Portfolio FSTX Stock Details FSTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-153,286	Closed	-$969K	–	114
2019 Q4	$969K	Hold	153,286	–	–	0.01%	94
2019 Q3	$2.11M	Hold	153,286	–	–	0.01%	85
2019 Q2	$2.26M	Hold	153,286	–	–	0.02%	81
2019 Q1	$6.43M	Hold	153,286	–	–	0.04%	54
2018 Q4	$6.37M	Hold	153,286	–	–	0.05%	53
2018 Q3	$7.39M	Buy	153,286 +60,000	+64%	+$3.01M	0.05%	60
2018 Q2	$4.42M	Hold	93,286	–	–	0.03%	82
2018 Q1	$5.74M	Hold	93,286	–	–	0.05%	73
2017 Q4	$5.01M	Hold	93,286	–	–	0.04%	77
2017 Q3	$6.28M	Hold	93,286	–	–	0.05%	71
2017 Q2	$5.05M	Buy	93,286 +38,461	+70%	+$1.78M	0.04%	65
2017 Q1	$1.95M	Hold	54,825	–	–	0.02%	90
2016 Q4	$1.75M	Buy	+54,825	New	+$2.01M	0.02%	95

Other funds holding FSTX

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Tiedemann Advisors New York $2.33B AUM 15.56% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCM

Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return

Exane Derivatives Paris, France $174M AUM 7.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PCA

Private Capital Advisors Darien, Connecticut $1.14B AUM 48.66% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return

Julian Baker's FSTX Position: Q1 2020 in Review

Julian Baker sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q1 2020, closing a stake of 153,286 shares — an estimated $969K sold.

Julian Baker first reported a position in FSTX in Q4 2016 and held it in 13 quarters. The position peaked at $7.39M in Q3 2018. 28 funds tracked by Wall St. Rank hold FSTX as of Q1 2020.

Julian Baker reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
Julian Baker sold 153,286 F-star Therapeutics, Inc. Common Stock shares in Q1 2020, an estimated $969K.
Julian Baker first reported a position in F-star Therapeutics, Inc. Common Stock in Q4 2016 and held it in 13 quarters.
Julian Baker's F-star Therapeutics, Inc. Common Stock position peaked at $7.39M in Q3 2018.
28 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q1 2020.

Based on Baker Bros. Advisors's 13F filing for Q1 2020, filed 15 May 2020.